The iBuying pioneer's stock retreated last month, reflecting broader market caution and the persistent challenges of a tight, high-rate housing environment, despite a recent leadership overhaul and strategic pivot.
Despite a deeper-than-expected cryptocurrency selloff, Fundstrat's Tom Lee argues key technical and fundamental signals suggest a market bottom is near for Bitcoin and Ethereum, citing price alignment and improving on-chain activity.
With AI chip power demands soaring, Vertiv Holdings Co's advanced cooling solutions are emerging as a critical bottleneck—and a strategic investment. Its deep partnership with Nvidia provides a key competitive edge in a market where reliability trumps cost.
Lean hog futures posted solid gains to start the week, buoyed by a stronger cash market and firming pork cutout values. Traders are positioning cautiously ahead of Wednesday's USDA Cold Storage report, which could dictate near-term price direction.
Soybean futures edged lower Wednesday morning, giving back a portion of the previous session's gains. The market is weighing new U.S. Treasury guidance on biofuel tax credits against a backdrop of softer EU import demand.
The South Korean automaker reported a sharp $1.9 billion decline in net profit for 2025, attributing the drop largely to U.S. import tariffs, even as it achieved a historic milestone of selling over 3 million vehicles worldwide.
The maker of blockbuster drugs Wegovy and Ozempic sees its stock plunge 18% after slashing profit forecasts, citing unprecedented competition, patent expiries, and a landmark U.S. pricing deal.
Learning management platform Docebo launches a significant share repurchase program, aiming to retire over 10% of its stock. Management frames the move as a response to undervaluation and a commitment to returning capital, even as the company navigates a competitive landscape and projects steady revenue growth.
Eli Lilly's blockbuster GLP-1 drugs continue to shatter expectations, propelling the company past rival Novo Nordisk and reshaping the pharmaceutical landscape with over $36.5 billion in combined sales for its leading treatments.
New data reveals a sharp 57% year-on-year drop in Tesla's UK registrations for January, with BYD outselling the US automaker by more than double. The figures highlight intensifying competition in the British electric vehicle market.
New analysis reveals North Carolina homeowners who sold off-market in 2025 missed out on an average of $51,000 per sale—a stark premium for privacy that in some counties amounted to nearly 60% of potential value.
A recent bilateral trade deal has slashed Canada's tariff on Chinese electric vehicles from 100% to 6.1%, creating a potential beachhead for China's auto industry in North America amidst ongoing regional trade tensions.
The Texas grocery giant has acquired over 600 acres for new distribution facilities, a strategic move to fuel its rapid retail expansion in the competitive Dallas-Fort Worth market.
H.C. Wainwright nearly doubles its price target for Americas Gold and Silver Corp. (USAS) to $9.75, citing strong quarterly production and the discovery of high-grade veins at its Galena Complex. The move signals growing confidence in the miner's operational momentum and resource expansion.
Scotiabank has raised its price target for IAMGold Corporation (IAG) to $23, citing record gold and silver price forecasts fueled by economic uncertainty and central bank demand. The move follows similar upgrades from other major banks.
Legacy Ridge Capital Management's latest investor letter reveals a cautious stance on Palantir Technologies despite its record revenue, highlighting valuation concerns and pointing investors toward alternative AI opportunities with potentially better risk-reward profiles.
A historic winter storm sweeping across the U.S. is cited as a key factor behind a significant 8.9% drop in mortgage applications, marking the second weekly decline and dampening early-year housing activity.
Powered by surging demand for its diabetes and weight-loss drugs, Eli Lilly delivered a fourth-quarter earnings beat and issued a bullish long-term forecast that far outpaces Wall Street expectations, sending its shares sharply higher.
Analysis of on-chain data and trading history reveals a notable lack of structural support or resistance between $70,000 and $80,000, suggesting Bitcoin's current consolidation could be prolonged or precede a significant test of lower levels.
Legacy Ridge Capital Management's latest investor letter reveals a 7% net return for 2025, highlighting Kimbell Royalty Partners (KRP) as a key holding poised for a significant dividend payout, even as concentrated value strategies face headwinds.
